RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy shows promise for Hard-to-Treat myeloma
Disease control Recruiting nowThis early-stage trial tests a new treatment for adults with multiple myeloma that has come back or not responded to other therapies. The treatment uses immune cells from donated cord blood that are specially designed to target and kill myeloma cells. The main goals are to check …
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New cell therapy shows promise for Hard-to-Treat blood cancer
Disease control Recruiting nowThis study tests a new treatment called LCAR-F33S for people with multiple myeloma that has come back or stopped responding to other therapies. The treatment uses a patient's own immune cells, modified to attack cancer cells. The main goals are to check safety and find the best d…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New CAR t therapy takes on tough myeloma cases
Disease control Recruiting nowThis early-stage study tests a new cell therapy called HBI0101 CAR T in 60 adults with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to better attack cancer cells. The main goals are to fin…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated May 04, 2026 16:20 UTC